Studies have shown that people with high levels of omega-3s are better protected against serious COVID-19 infections.

Published Date: 02 Mar 2023

A study recently published in the American Journal of Clinical Nutrition (AJCN) investigated the role of omega-3 fatty acids, specifically EPA and DHA, and whether they can prevent poor and/or negative weight loss. .

Read Full News

Latest News

RSV Hospitalization Burden Rises With Age and Comorbidities

Respiratory syncytial virus is associated with a greater burden of hospitalizations in older adults and in those with congestive heart failure or chronic obstructive pulmonary disease.

US Vaccine Advisers Drop Plan to Question MRNA COVID Shots, WaPo Reports

A key U.S. federal vaccine advisory panel has dropped a push against COVID mRNA vaccines, ⁠the Washington Post reported on Wednesday, citing two people familiar with the...

No Link Between HPV Vaccination and Infertility

A Cochrane review of 225 studies covering 132 million vaccinated people found, with high certainty, that HPV vaccination does not cause fertility problems, refuting a common myth.

South Carolina Reports One Additional Measles Case, Total Cases Rise to 991

Measles cases in South Carolina rose to 991 on Friday, state health data ⁠showed, an increase of one case since Tuesday as the nation's largest outbreak in ⁠decades shows...

mRNA RSV Vaccine Safe in Transplant Recipients

mRNA-1345 vaccine is safe and well tolerated and elicits measurable antibody and cellular immune responses in recipients with solid organ transplant.

HIV Hits the Nervous System Early

Cerebrospinal fluid samples show signs of inflammation.

Todays Updates

Chemoimmunotherapy Boosts Head and Neck Cancer Response

Neoadjuvant chemoimmunotherapy may beat immunotherapy alone when it comes to pathologic response, but its impact on survival remains to be seen.

Todays Updates

Chemoimmunotherapy Boosts Head and Neck Cancer Response

Neoadjuvant chemoimmunotherapy may beat immunotherapy alone when it comes to pathologic response, but its impact on survival remains to be seen.

Latest News

Respiratory syncytial virus is associated with a greater burden of hospitalizations in older adults and in those with congestive heart failure or chronic obstructive pulmonary disease.

A key U.S. federal vaccine advisory panel has dropped a push against COVID mRNA vaccines, ⁠the Washington Post reported on Wednesday, citing two people familiar with the...

A Cochrane review of 225 studies covering 132 million vaccinated people found, with high certainty, that HPV vaccination does not cause fertility problems, refuting a common myth.

Measles cases in South Carolina rose to 991 on Friday, state health data ⁠showed, an increase of one case since Tuesday as the nation's largest outbreak in ⁠decades shows...

mRNA-1345 vaccine is safe and well tolerated and elicits measurable antibody and cellular immune responses in recipients with solid organ transplant.

Cerebrospinal fluid samples show signs of inflammation.

News All Time

CDC Acting Director Bhattacharya Urges Use of Measles Vaccine

The U.S. Centers for Disease Control and Prevention's new acting director, Jay Bhattacharya, on Monday urged Americans to get vaccinated against ⁠measles, saying it was the...

Longevity Research Is a Public Health Imperative: Barzilai

From healthcare costs to cancer survival and even space travel, Nir Barzilai explains why targeting aging is crucial for our entire society.

Africa CDC Cites Concerns Over Data Sharing in US Health Deals

There are big issues in health funding deals the US is pursuing with African countries, the head of the African CDC said Thursday.

U.S. Surgeon General Nominee Means Says She Backs Vaccines, With Parental Conversations

Casey Means, President ⁠Donald Trump's nominee for U.S. ⁠surgeon general and an ally of ⁠Health Secretary ‌Robert F. Kennedy Jr., said before the Senate's Health, Education,...

South Carolina Measles Cases Easing Earlier Than Expected, Health Official Says

South Carolina has reported a drop in measles cases over the past ⁠two weeks, an encouraging sign that the outbreak may be easing earlier than anticipated, a state health...

FDA Vaccine Advisers to Meet in March on Flu Strain Selection

The U.S. Food and Drug Administration said on Wednesday ⁠its advisory committee is set to meet on March 12 to ⁠discuss and make recommendations on the strain composition of...

Gilead's Experimental HIV Treatment Shows Low Discontinuation Rates in Studies

Gilead Sciences on Wednesday said its experimental single-tablet HIV treatment was ⁠generally well tolerated with low discontinuation rates, positioning the single-tablet...

CROI 2026

Read clinically focused news coverage of key developments from CROI 2026.

Response to RSV Varies With Age

Tissue modeling outlines how respiratory syncytial virus promotes different disease outcomes in children and adults.

US CDC Vaccine Panel to Meet in March After February Session Scrapped

The U.S. Centers for Disease Control and Prevention's vaccine advisory committee is set to meet on March ⁠18 to 19, an update on the agency's website showed on Tuesday,...

Long-Acting HIV Drug Switch Shows No Major Metabolic Impact

In patients with HIV infection, a switch to long acting cabotegravir plus rilpivirine shows no clinically meaningful changes in body composition or adverse metabolic effects over 48 weeks.

Zimbabwe Ends $367 Million Health Funding Talks With US

Zimbabwe has pulled out of talks on a $367 million bilateral health agreement with the US due to concerns over sharing sensitive health data in return for financial support.

Mobile Telemedicine Boosts Rural Access to HCV Treatment

Among rural people with chronic HCV infection and a history of injection drug use, a mobile telemedicine-based intervention vs enhanced usual care improves treatment initiation and cure rates.

RSV Vaccine in Multidose Vial Matches Single-Dose Vial

In healthy, nonpregnant women, the multidose vial of RSVpreF vaccine produces immune responses and safety outcomes comparable to the single-dose vial, a trial finds.

US FDA Reverses Course, Will Review Moderna's Flu Vaccine Application

Moderna said on Wednesday the U.S. Food and Drug Administration changed course and will review an amended application for its new flu vaccine, a week after rejecting the...